JFNAX
Price
$85.72
Change
-$0.67 (-0.78%)
Updated
Sep 10 closing price
Net Assets
6.03B
SHSAX
Price
$62.92
Change
-$0.10 (-0.16%)
Updated
Sep 11 closing price
Net Assets
6.17B
Interact to see
Advertisement

JFNAX vs SHSAX

JFNAX vs SHSAX Comparison Chart in %
View a ticker or compare two or three
VS
JFNAX vs. SHSAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNAX is a Hold and SHSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX (6.17B) and JFNAX (6.03B) have equal amount of cash in the bank . JFNAX pays higher dividends than SHSAX: JFNAX (0.29) vs SHSAX (0.26). JFNAX was incepted earlier than SHSAX: JFNAX (17 years) vs SHSAX (27 years). SHSAX (1.09) is less costly to investors than JFNAX (1.00). SHSAX is a more actively managed with annual turnover of: 43.00 vs. JFNAX (30.00). JFNAX initial investment is less costly to investors than SHSAX (5%) vs SHSAX (5%). SHSAX has a lower initial minimum investment than JFNAX: SHSAX (1000) vs JFNAX (2500). JFNAX annual gain was more profitable for investors over the last year : 24.92 vs. SHSAX (4.10). JFNAX return over 5 years is better than : 16.95 vs. SHSAX (-17.90).
JFNAXSHSAXJFNAX / SHSAX
Total Expense Ratio1.001.0992%
Annual Report Gross Expense Ratio1.001.0992%
Fund Existence17 years27 years-
Gain YTD8.671-2.642-328%
Front Load6%5%110%
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets6.03B6.17B98%
Annual Yield % from dividends0.290.26111%
Returns for 1 year24.924.10607%
Returns for 3 years27.34-2.23-1,224%
Returns for 5 years16.95-17.90-95%
Returns for 10 years80.9134.80233%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRT257.068.93
+3.60%
Vertiv Holdings Co
EXP185.121.35
+0.73%
Eagle Materials
MNKD3.75-0.04
-1.06%
MannKind Corp
LTRN1.71-0.05
-2.84%
Lantern Pharma
RNAC8.19-0.24
-2.85%
Cartesian Therapeutics